Abstract
Since the discovery of human T cell leukemia/lymphoma virus type I (HTLV-I) [5], the immune status of HTLV-I- infected hosts, including patients with adult T cell leukemia (ATL), has not yet been sufficiently investigated [2–4]. As the first step in this kind of study, we have studied the nonspecific activity of peripheral mononuclear cells (PMNC) from ATL patients and seropositive HTLV-I carriers and therole of HTLV-I p19 antigen and HTLV-I-producing cell surface antigens in the host immune responses to HTLV-I.KeywordsNatural Killer ActivityComplement SourceDucing CellNonspecific Immune ActivitySeronegative Healthy DonorThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
